In Brief This Week: Chembio Diagnostics, Thermo Fisher Scientific, Renalytix, Theralink, More
News items for the week of Nov. 28, 2022.
360Dx Top 30 Rises 2 Percent After Months of Decline
Of the 30 companies in the index, 22 saw their stock prices rise, while eight firms saw their share prices decrease.
Renalytix Posts $2.9M in Revenue for Fiscal 2022
The kidney disease-focused in vitro diagnostics firm nearly doubled the previous year's revenue and posted a net loss of $45.3 million in the year ending June 30.
360Dx Top 30 Drops 5 Percent in June
Of the 30 diagnostic companies in the index, nine saw their share prices increase, while 21 saw stock prices decline.
In Brief This Week: Qiagen, Renalytix, OpGen, PerkinElmer, Avacta, Paige, More
News items for the in vitro diagnostics industry for the week of April 4, 2022.
Dec 7, 2021
Renalytix Posts $482K in Fiscal Q1 Revenues
Oct 21, 2021